MedTrace Logo

Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer

NCT04943406 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-10-06

No results posted yet for this study

Summary

This study investigates the prognostic role of liquid biopsy in patients with locally advanced gastric cancer.

Liquid biopsy for the detection of circulating tumor DNA will be performed:

* In the peritoneal lavage, during staging laparoscopy (if indicated) and during curative gastrectomy
* In plasma, before staging laparoscopy (if indicated), before curative gastrectomy, at hospital discharge, three months after surgery/at the end of adjuvant therapy, and in case of disease recurrence.

The aim of this study is to determine the predictive power of liquid biopsy on overall survival and disease free survival.

Conditions

Sponsors & Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    lead OTHER

Principal Investigators

  • Carlo Sposito, MD · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-08
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943406 on ClinicalTrials.gov